Research Topics
Genomes and Genes | Sunil KrishnanSummaryAffiliation: The University of Texas Country: USA Publications
| Collaborators
|
Detail Information
Publications
A mouse model for triple-negative breast cancer tumor-initiating cells (TNBC-TICs) exhibits similar aggressive phenotype to the human diseasePunit Kau
Department of Pathology, Scott and White Memorial Hospital and Clinic and the Texas A and M Health Science Center, College of Medicine, Temple, TX 76504, USA
BMC Cancer 12:120. 2012..The reason for this aggressive phenotype is currently the focus of intensive research. However, progress is hampered by the lack of suitable TNBC cell model systems...
Induction chemotherapy selects patients with locally advanced, unresectable pancreatic cancer for optimal benefit from consolidative chemoradiation therapySunil Krishnan
Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030 4009, USA
Cancer 110:47-55. 2007....
Radiotherapy for hepatocellular carcinoma: an overviewSunil Krishnan
Division of Radiation Oncology, M. D. Anderson Cancer Center, 1515 Holcombe Blvd, Unit 097, Houston, Texas 77030, United States
Ann Surg Oncol 15:1015-24. 2008
Daily targeting of liver tumors: screening patients with a mock treatment and using a combination of internal and external fiducials for image-guided respiratory-gated radiotherapySunil Krishnan
Department of Radiation Oncology, MD Anderson Cancer Center, Houston, Texas 77030, USA
Med Phys 34:4591-3. 2007..This technique could screen patients for gated therapy, reduce setup inaccuracy, and possibly individualize treatment margins...
Prognostic factors in patients with unresectable locally advanced pancreatic adenocarcinoma treated with chemoradiationSunil Krishnan
Department of Radiation Oncology, The University of Texas, M D Anderson Cancer Center, Houston, Texas, USA
Cancer 107:2589-96. 2006..Prognostic factors are inadequately defined for disease-free survival and overall survival in patients with LAPC who are receiving chemoradiation, so more definitive prognostic factors would be very useful for designing clinical trials...
Nanoparticle-mediated thermal therapy: evolving strategies for prostate cancer therapySunil Krishnan
Department of Radiation Oncology, University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
Int J Hyperthermia 26:775-89. 2010..Capitalising on these opportunities and overcoming these challenges offers the possibility of seamless and logical translation of this nanoparticle-mediated hyperthermia paradigm from the bench to the bedside...
Phase I trial of erlotinib with radiation therapy in patients with glioblastoma multiforme: results of North Central Cancer Treatment Group protocol N0177Sunil Krishnan
Department of Radiation Oncology, Mayo Clinic College of Medicine, Rochester, MN, USA
Int J Radiat Oncol Biol Phys 65:1192-9. 2006..To evaluate the toxicity and maximum tolerated dose (MTD) of erlotinib plus radiation therapy (RT) in patients with glioblastoma multiforme (GBM) in a multicenter phase I trial...
Resveratrol, a multitargeted agent, can enhance antitumor activity of gemcitabine in vitro and in orthotopic mouse model of human pancreatic cancerKuzhuvelil B Harikumar
Department of Experimental Therapeutics, The University of Texas M D Anderson Cancer Center, Houston, TX, USA
Int J Cancer 127:257-68. 2010..Overall our results demonstrate that resveratrol can potentiate the effects of gemcitabine through suppression of markers of proliferation, invasion, angiogenesis and metastasis...
Curcumin sensitizes human colorectal cancer to capecitabine by modulation of cyclin D1, COX-2, MMP-9, VEGF and CXCR4 expression in an orthotopic mouse modelAjaikumar B Kunnumakkara
Department of Experimental Therapeutics, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
Int J Cancer 125:2187-97. 2009..Overall, our results suggest that curcumin sensitizes CRC to the antitumor and antimetastatic effects of capecitabine by suppressing NF-kappaB cell signaling pathway...
Hyperfractionated accelerated radiotherapy for rectal cancer in patients with prior pelvic irradiationPrajnan Das
Department of Radiation Oncology, University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
Int J Radiat Oncol Biol Phys 77:60-5. 2010..To retrospectively determine rates of toxicity, freedom from local progression, and survival in rectal cancer patients treated with reirradiation...
Role of adjuvant chemoradiation therapy in adenocarcinomas of the ampulla of vaterSunil Krishnan
Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030 4009, USA
Int J Radiat Oncol Biol Phys 70:735-43. 2008..We retrospectively compared treatment outcomes in patients treated with pancreaticoduodenectomy alone versus those who received additional adjuvant CRT...
Intensity-modulated radiation therapy with concurrent chemotherapy as preoperative treatment for localized gastric adenocarcinomaTwisha Chakravarty
Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
Int J Radiat Oncol Biol Phys 83:581-6. 2012....
Ursolic acid inhibits growth and metastasis of human colorectal cancer in an orthotopic nude mouse model by targeting multiple cell signaling pathways: chemosensitization with capecitabineSahdeo Prasad
Cytokine Research Laboratory, Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
Clin Cancer Res 18:4942-53. 2012..The effect of ursolic acid on the growth and chemosensitization was also examined in orthotopically implanted CRC in nude mice...
Concurrent capecitabine and upper abdominal radiation therapy is well toleratedPrajnan Das
Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, USA
Radiat Oncol 1:41. 2006..Therefore, capecitabine and concurrent radiotherapy to the upper abdomen appears to be well tolerated. Capecitabine may serve as an alternative to bolus or infusional 5-FU during chemoradiation for upper gastrointestinal malignancies...
Phase II trial of neoadjuvant bevacizumab, capecitabine, and radiotherapy for locally advanced rectal cancerChristopher H Crane
Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
Int J Radiat Oncol Biol Phys 76:824-30. 2010..We designed this Phase II trial to assess the efficacy and safety of the addition of bevacizumab to concurrent neoadjuvant capecitabine-based chemoradiation in locally advanced rectal cancer...
Reproducibility and genital sparing with a vaginal dilator used for female anal cancer patientsTina Marie Briere
Department of Radiation Physics, UT MD Anderson Cancer Center, Houston, TX 77030, United States
Radiother Oncol 104:161-6. 2012..A vaginal dilator may help delineate and displace the vulva and lower vagina away from the primary tumor. The goal of this study was to evaluate the positional reproducibility and vaginal sparing with the use of a vaginal dilator...
Zyflamend suppresses growth and sensitizes human pancreatic tumors to gemcitabine in an orthotopic mouse model through modulation of multiple targetsAjaikumar B Kunnumakkara
Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
Int J Cancer 131:E292-303. 2012....
Sacral insufficiency fractures after preoperative chemoradiation for rectal cancer: incidence, risk factors, and clinical courseMichael P Herman
Department of Radiation Oncology, UT MD Anderson Cancer Center, Houston, TX 77030, USA
Int J Radiat Oncol Biol Phys 74:818-23. 2009..Our goal was to determine the incidence, risk factors, and clinical course of SI fractures in patients treated with preoperative chemoradiation for rectal cancer...
Patterns of locoregional recurrence after surgery and radiotherapy or chemoradiation for rectal cancerTse Kuan Yu
Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
Int J Radiat Oncol Biol Phys 71:1175-80. 2008..To identify patterns of locoregional recurrence in patients treated with surgery and preoperative or postoperative radiotherapy or chemoradiation for rectal cancer...
Curcumin sensitizes human colorectal cancer xenografts in nude mice to gamma-radiation by targeting nuclear factor-kappaB-regulated gene productsAjaikumar B Kunnumakkara
Department of Experimental Therapeutics, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
Clin Cancer Res 14:2128-36. 2008..Because curcumin, a component of turmeric (Curcuma longa), has been shown to suppress NF-kappaB activation, whether it can sensitize the colorectal cancer to gamma-radiation was investigated in colorectal cancer xenografts in nude mice...
Predictors of tumor response and downstaging in patients who receive preoperative chemoradiation for rectal cancerPrajnan Das
Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
Cancer 109:1750-5. 2007..The objective of this study was to identify predictive factors for pathologic complete response and tumor downstaging after preoperative chemoradiation for rectal cancer...
Preoperative chemoradiotherapy with capecitabine versus protracted infusion 5-fluorouracil for rectal cancer: a matched-pair analysisPrajnan Das
Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
Int J Radiat Oncol Biol Phys 66:1378-83. 2006....
{Gamma}-tocotrienol inhibits pancreatic tumors and sensitizes them to gemcitabine treatment by modulating the inflammatory microenvironmentAjaikumar B Kunnumakkara
Department of Experimental Therapeutics, University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA
Cancer Res 70:8695-705. 2010..Overall, our findings suggest that γ-T3 can inhibit the growth of human pancreatic tumors and sensitize them to gemcitabine by suppressing NF-κB-mediated inflammatory pathways linked to tumorigenesis...
Duodenal toxicity after fractionated chemoradiation for unresectable pancreatic cancerPatrick Kelly
Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
Int J Radiat Oncol Biol Phys 85:e143-9. 2013..In order to guide future studies, we analyzed the clinical and dosimetric factors associated with duodenal toxicity in patients undergoing fractionated chemoradiation for LAPC...
Neoadjuvant treatment response as an early response indicator for patients with rectal cancerIn Ja Park
The University of Texas MD Anderson Cancer Center, Houston, TX 77230 1402, USA
J Clin Oncol 30:1770-6. 2012..The purpose of this study was to assess and compare oncologic outcomes associated with the degree of pathologic response after chemoradiotherapy...
Radiation treatment outcomes for unresectable hepatocellular carcinomaHeath D Skinner
Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, 77030, USA
Acta Oncol 50:1191-8. 2011..Data regarding the use of radiotherapy is limited in patients from populations without endemic viral hepatitis. We examine the outcomes for patients treated with radiotherapy in the modern era at a single institution...
Chemoradiation therapy for potentially resectable gastric cancer: clinical outcomes among patients who do not undergo planned surgeryMichelle M Kim
Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
Int J Radiat Oncol Biol Phys 71:167-72. 2008....
Local excision after preoperative chemoradiation results in an equivalent outcome to total mesorectal excision in selected patients with T3 rectal cancerGlenda G Callender
Department of Surgical Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX, USA
Ann Surg Oncol 17:441-7. 2010..At nearly 4 years' follow-up, no difference in outcome was observed. This study compares outcomes in a larger cohort of patients and reevaluates the original 26 patients after longer follow-up...
Phase II trial of cetuximab, gemcitabine, and oxaliplatin followed by chemoradiation with cetuximab for locally advanced (T4) pancreatic adenocarcinoma: correlation of Smad4(Dpc4) immunostaining with pattern of disease progressionChristopher H Crane
Dept of Radiation Oncology, Unit 97, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX
J Clin Oncol 29:3037-43. 2011..This phase II trial was designed to assess the efficacy and safety of cetuximab, gemcitabine, and oxaliplatin followed by cetuximab, capecitabine, and radiation therapy in locally advanced pancreatic cancer (LAPC)...
Long-term survival after multidisciplinary management of resected pancreatic adenocarcinomaMatthew H G Katz
Department of Surgical Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX, USA
Ann Surg Oncol 16:836-47. 2009..We evaluated long-term survival and patterns of recurrence in patients treated for PC with contemporary staging and multimodality therapy...
Temporal patterns of fatigue predict pathologic response in patients treated with preoperative chemoradiation therapy for rectal cancerHee Chul Park
Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030 4009, USA
Int J Radiat Oncol Biol Phys 75:775-81. 2009..To investigate whether symptom burden before and during preoperative chemoradiation therapy (CRT) for rectal cancer predicts for pathologic tumor response...
Number of lymph nodes examined and prognosis among pathologically lymph node-negative patients after preoperative chemoradiation therapy for rectal adenocarcinomaChiaojung Jillian Tsai
Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA
Cancer 117:3713-22. 2011....
Preoperative gemcitabine and cisplatin followed by gemcitabine-based chemoradiation for resectable adenocarcinoma of the pancreatic headGauri R Varadhachary
Department of Gastrointestinal Medical Oncology, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Blvd, Box 426, Houston, TX 77030, USA
J Clin Oncol 26:3487-95. 2008..We conducted a phase II trial of preoperative gemcitabine and cisplatin chemotherapy in addition to chemoradiation (Gem-Cis-XRT) and pancreaticoduodenectomy (PD) for patients with stage I/II pancreatic adenocarcinoma...
Clinical benefit of palliative radiation therapy in advanced gastric cancerMichelle M Kim
Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
Acta Oncol 47:421-7. 2008..Local progression of advanced gastric cancer often manifests as bleeding, dysphagia/obstruction, or pain. We evaluated the magnitude and durability of palliation with radiotherapy (RT)...
Incidence, natural history, and patterns of locoregional recurrence in gastric cancer patients treated with preoperative chemoradiotherapyValerie K Reed
Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
Int J Radiat Oncol Biol Phys 71:741-7. 2008..To retrospectively determine the incidence and patterns (in-field, marginal, or out-of-field) of locoregional gastric cancer recurrence in patients who received preoperative chemoradiotherapy and to determine the outcome in these patients...
Boswellic acid inhibits growth and metastasis of human colorectal cancer in orthotopic mouse model by downregulating inflammatory, proliferative, invasive and angiogenic biomarkersVivek R Yadav
Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
Int J Cancer 130:2176-84. 2012..Thus, our findings suggest that this boswellic acid analog can inhibit the growth and metastasis of human CRC in vivo through downregulation of cancer-associated biomarkers...
A novel small-molecule inhibitor of protein kinase D blocks pancreatic cancer growth in vitro and in vivoKuzhuvelil B Harikumar
Department of Experimental Therapeutics, The UT MD Anderson Cancer Center, Houston, Texas, USA
Mol Cancer Ther 9:1136-46. 2010..Our results show for the first time that a PKD-specific small-molecule inhibitor CRT0066101 blocks pancreatic cancer growth in vivo and show that PKD is a novel therapeutic target in pancreatic cancer...
Sesamin manifests chemopreventive effects through the suppression of NF-kappa B-regulated cell survival, proliferation, invasion, and angiogenic gene productsKuzhuvelil B Harikumar
Cytokine Research Laboratory, Department of Experimental Therapeutics, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
Mol Cancer Res 8:751-61. 2010..Overall, our results showed that sesamin may have potential against cancer and other chronic diseases through the suppression of a pathway linked to the NF-kappaB signaling...
Phase II study of capecitabine (Xeloda) and concomitant boost radiotherapy in patients with locally advanced rectal cancerSunil Krishnan
Department of Radiation Oncology, The University of Texas, M.D. Anderson Cancer Center, Houston, TX, USA
Int J Radiat Oncol Biol Phys 66:762-71. 2006..The pathologic response rate is comparable to our previous experience using protracted venous infusion 5-FU for LARC...
Phase I/II trial of erlotinib and temozolomide with radiation therapy in the treatment of newly diagnosed glioblastoma multiforme: North Central Cancer Treatment Group Study N0177Paul D Brown
Mayo Clinic and Mayo Foundation, Rochester, MN 55905, USA
J Clin Oncol 26:5603-9. 2008..Erlotinib, a selective EGFR inhibitor, was combined with temozolomide (TMZ) and radiotherapy (RT) in a phase I/II trial...
Predictors and patterns of recurrence after definitive chemoradiation for anal cancerPrajnan Das
Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
Int J Radiat Oncol Biol Phys 68:794-800. 2007..To evaluate patterns of locoregional failure, and predictors of recurrence and survival in patients treated with chemoradiation for anal cancer...
Improving soft-tissue contrast in four-dimensional computed tomography images of liver cancer patients using a deformable image registration methodHe Wang
Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
Int J Radiat Oncol Biol Phys 72:201-9. 2008..To investigate a deformable image registration method to improve soft-tissue contrast in four-dimensional (4D) computed tomography (CT) images of the liver...
Intensity-modulated radiation therapy for the treatment of squamous cell anal cancer with para-aortic nodal involvementJoseph C Hodges
Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA
Int J Radiat Oncol Biol Phys 75:791-4. 2009....
Curcumin modulates the radiosensitivity of colorectal cancer cells by suppressing constitutive and inducible NF-kappaB activitySantosh K Sandur
Department of Experimental Therapeutics, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
Int J Radiat Oncol Biol Phys 75:534-42. 2009..Simultaneous inhibition of these pathways can sensitize these tumors to radiation therapy...
Intensity modulated radiation therapy (IMRT): differences in target volumes and improvement in clinically relevant doses to small bowel in rectal carcinomaHenry Mok
Department of Radiation Oncology, The University of Texas, M, d, Anderson Cancer Center, Houston, Texas, USA
Radiat Oncol 6:63. 2011..Therefore, we performed a comprehensive dosimetric evaluation of IMRT compared to 3-dimensional conformal radiation therapy (3DCRT) in standard, preoperative treatment for rectal cancer...
Hepatic yttrium-90 radioembolotherapy in metastatic colorectal cancer treated with cetuximab or bevacizumabRavi Murthy
Department of Diagnostic Radiology, Interventional Radiology Section, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, Texas 77030, USA
J Vasc Interv Radiol 18:1588-91. 2007..This report briefly describes the authors' treatment experience with this cohort of patients...
Escin, a pentacyclic triterpene, chemosensitizes human tumor cells through inhibition of nuclear factor-kappaB signaling pathwayKuzhuvelil B Harikumar
Department of Experimental Therapeutics, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
Mol Pharmacol 77:818-27. 2010....
Respiratory gating with EPID-based verification: the MDACC experienceTina Marie Briere
Department of Radiation Physics, MD Anderson Cancer Center, Houston, TX 77030, USA
Phys Med Biol 54:3379-91. 2009..Daily assessment of images acquired during treatment verifies the accuracy of the delivered treatment and uncovers problems in patient set-up...
Inhibition of radiation-induced DNA repair and prosurvival pathways contributes to vorinostat-mediated radiosensitization of pancreatic cancer cellsAmit Deorukhkar
Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
Pancreas 39:1277-83. 2010....
Serum sTNF-R1, IL-6, and the development of fatigue in patients with gastrointestinal cancer undergoing chemoradiation therapyXin Shelley Wang
Department of Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
Brain Behav Immun 26:699-705. 2012..0001). This longitudinal study suggests a role for over-expressed sTNF-R1 and IL-6 in the development of fatigue and other severe sickness symptoms during CXRT in patients with colorectal or esophageal cancer...
Long-term survival and recurrence outcomes following surgery for distal rectal cancerEric J Silberfein
Department of Surgical Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX, USA
Ann Surg Oncol 17:2863-9. 2010..The purpose of this study is to evaluate operative and pathologic factors associated with long-term survival and local recurrence outcomes in patients treated for distal rectal cancer...
Risk of second malignant neoplasm following proton versus intensity-modulated photon radiotherapies for hepatocellular carcinomaPhillip J Taddei
Division of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
Phys Med Biol 55:7055-65. 2010..4% after PBT and 19.2% after IMRT. The results of this study suggest that using proton beams instead of photon beams for radiotherapy may reduce the risk of SMN incidence for some HCC patients...
The optimization of dose delivery for intraoperative high-dose-rate radiation therapy using curved HAM applicatorsA Sam Beddar
Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
Radiother Oncol 78:207-12. 2006..To determine the effect of the curvature of Harrison-Anderson-Mick applicators on the dose distribution in high-dose-rate intraoperative radiation therapy (HDR-IORT)...
Long-term quality of life after radiotherapy for the treatment of anal cancerPrajnan Das
Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston1515 Holcombe Boulevard, Unit 97, Houston, TX 77030, USA
Cancer 116:822-9. 2010..Radiotherapy is the current standard of care for patients with localized squamous cell cancer of the anal canal. The goal of the current study was to evaluate long-term quality of life (QoL) in patients after this treatment...
Therapeutic significance of elevated tissue transglutaminase expression in pancreatic cancerAmit Verma
Department of Experimental Therapeutics, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
Clin Cancer Res 14:2476-83. 2008..Therefore, we examined therapeutic targeting of TG2 for inhibiting growth and metastasis of in vivo growing pancreatic ductal adenocarcinoma (PDAC) in nude mice...
Conformal radiotherapy of the dominant liver metastasis: a viable strategy for treatment of unresectable chemotherapy refractory colorectal cancer liver metastasesSunil Krishnan
Department of Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA
Am J Clin Oncol 29:562-7. 2006..CONCLUSIONS: Conformal RT to the dominant liver metastasis as palliative therapy for unresectable colorectal cancer liver metastases has an acceptable toxicity profile and may improve survival. This approach merits further exploration...
Proton radiotherapy for liver tumors: dosimetric advantages over photon plansXiaochun Wang
Department of Radiation Physics, The University of Texas, M D Anderson Cancer Center, Houston, TX 77030, USA
Med Dosim 33:259-67. 2008..In conclusion, our study suggests the dosimetric benefits of proton radiotherapy over photon radiotherapy. These dosimetric advantages of proton plans may permit further dose escalation with lower risk of complications...
Modulation of in vivo tumor radiation response via gold nanoshell-mediated vascular-focused hyperthermia: characterizing an integrated antihypoxic and localized vascular disrupting targeting strategyParmeswaran Diagaradjane
Department of Experimental Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas, USA
Nano Lett 8:1492-500. 2008..This novel integrated antihypoxic and localized vascular disrupting therapy can potentially be combined with other conventional antitumor therapies...
Extrahepatic bile duct adenocarcinoma: patients at high-risk for local recurrence treated with surgery and adjuvant chemoradiation have an equivalent overall survival to patients with standard-risk treated with surgery aloneYerko Borghero
Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Blvd, Unit 97, Houston, TX 77030, USA
Ann Surg Oncol 15:3147-56. 2008....
Frequent loss of heterozygosity of chromosome 1q in esophageal adenocarcinoma: loss of chromosome 1q21.3 is associated with shorter overall survivalDipen M Maru
Department of Pathology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
Cancer 115:1576-85. 2009..It was unclear whether this difference was due to loss of heterozygosity (LOH) or to other genetic alterations at this locus...
Capecitabine and timing of radiotherapy during preoperative chemoradiation for rectal cancerManpreet Bedi
Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX
Gastrointest Cancer Res 1:44-8. 2007..We retrospectively investigated whether the timing of radiotherapy affects rates of acute toxicity, pathologic response, and relapse in rectal cancer patients receiving capecitabine...
Gadolinium chloride augments tumor-specific imaging of targeted quantum dots in vivoParmeswaran Diagaradjane
Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
ACS Nano 4:4131-41. 2010..This pretreatment strategy could have broad applicability across biomedical applications utilizing theranostic nanoparticles that are sequestered by the RES...
Does neoadjuvant treatment for gastric cancer patients with positive peritoneal cytology at staging laparoscopy improve survival?Brian Badgwell
Department of Surgical Oncology, Unit 444, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Boulevard, P O Box 301402, Houston, TX, 77030, USA
Ann Surg Oncol 15:2684-91. 2008....
Role of definitive radiation therapy in carcinoma of unknown primary in the abdomen and pelvisPatrick Kelly
Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
Int J Radiat Oncol Biol Phys 82:2012-7. 2012..In this study, we determined the effectiveness of radiation therapy in combination with chemotherapy in patients with CUP in the abdomen and pelvis...
Reirradiation to the abdomen for gastrointestinal malignanciesWaqar Haque
Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA
Radiat Oncol 4:55. 2009..Our goal was to retrospectively determine rates of toxicity, freedom from local progression and overall survival in gastrointestinal cancer patients treated with reirradiation to the abdomen...
Neutrophil gelatinase-associated lipocalin: a novel suppressor of invasion and angiogenesis in pancreatic cancerZhimin Tong
Department of Gastroenterology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA
Cancer Res 68:6100-8. 2008..Thus, NGAL is a potential suppressor of invasion and angiogenesis in advanced PaCa...
Targeting inflammatory pathways for tumor radiosensitizationAmit Deorukhkar
Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
Biochem Pharmacol 80:1904-14. 2010..We review recent data demonstrating the pivotal role played by inflammatory pathways in cancer progression and modulation of radiation response...
Phase II trial of carmustine, cisplatin, and oral etoposide chemotherapy before radiotherapy for grade 3 astrocytoma (anaplastic astrocytoma): results of North Central Cancer Treatment Group trial 98-72-51Ravi D Rao
Division of Medical Oncology, Department of Oncology, Mayo Clinic College of Medicine, Rochester, MN 55905 USA
Int J Radiat Oncol Biol Phys 61:380-6. 2005..However, 14 patients had died by 700 days after therapy. CONCLUSION: Our results have demonstrated that pre-RT chemotherapy with this regimen is insufficiently active in patients with anaplastic astrocytoma...
Correlation between internal fiducial tumor motion and external marker motion for liver tumors imaged with 4D-CTA Sam Beddar
Department of Radiation Physics, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
Int J Radiat Oncol Biol Phys 67:630-8. 2007..We investigated the correlation between the motions of an external marker and internal fiducials implanted in the liver for 8 patients undergoing respiratory-based computed tomography (four-dimensional CT [4D-CT]) procedures...
Modification of the cysteine residues in IkappaBalpha kinase and NF-kappaB (p65) by xanthohumol leads to suppression of NF-kappaB-regulated gene products and potentiation of apoptosis in leukemia cellsKuzhuvelil B Harikumar
Cytokine Research Laboratory, Department of Experimental Therapeutics, University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
Blood 113:2003-13. 2009..Thus, our results show that modification of cysteine residues of IKK and p65 by XN leads to inhibition of the NF-kappaB activation pathway, suppression of antiapoptotic gene products, and potentiation of apoptosis in leukemia cells...
Clinical and prognostic implications of plasma insulin-like growth factor-1 and vascular endothelial growth factor in patients with hepatocellular carcinomaAhmed O Kaseb
Department of Gastrointestinal Medical Oncology, Unit 426, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
J Clin Oncol 29:3892-9. 2011..The study objective was to improve prognostic stratification of patients with HCC...
Effect of combining anti-epidermal growth factor receptor antibody C225 and radiation on DU145 prostate cancerMatthew Wagener
Department of Radiation Oncology, UT MD Anderson Cancer Center, Houston, TX 77030, USA
Oncol Rep 19:1071-7. 2008..We drew the conclusion that the inhibition of EGFR augments the radiation killing of DU145 prostate cancer via a combination of cytostatic, necrotic and apoptotic mechanisms...
Retrospective study of clinicopathologic features and prognosis of high-grade neuroendocrine carcinoma of the esophagusDipen M Maru
Department of Pathology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
Am J Surg Pathol 32:1404-11. 2008..031). There was no difference in prognosis between patients with large-cell NEC and those with small-cell neuroendocrine carcinoma. Esophageal NEC is an aggressive tumor, and patients with mix NEC have better outcome...
Adjuvant therapy for ampullary carcinomas: the Mayo Clinic experienceSumita Bhatia
Department of Radiation Oncology, Mayo Clinic, Rochester, MN 55905, USA
Int J Radiat Oncol Biol Phys 66:514-9. 2006..The effect of adjuvant therapy on outcomes for patients with poor histologic grade or T3/T4 tumors without LN involvement could not be assessed...
Methodology for determining doses to in-field, out-of-field and partially in-field organs for late effects studies in photon radiotherapyRebecca M Howell
Graduate School of Biomedical Sciences, The University of Texas Health Science Center, Houston, TX 77030, USA
Phys Med Biol 55:7009-23. 2010..e. >5%. In such cases, we suggest supplementing calculated DVH data with measured dosimetric data using a volume-weighting technique to determine the mean dose...
4D-CT imaging with synchronized intravenous contrast injection to improve delineation of liver tumors for treatment planningA Sam Beddar
Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, TX 77030, USA
Radiother Oncol 87:445-8. 2008..Combined 4D-CT imaging with synchronized IV contrast allows for both enhancement of tumor contrast and coverage over the entire breathing cycle...
Clinical and pathologic predictors of locoregional recurrence, distant metastasis, and overall survival in patients treated with chemoradiation and mesorectal excision for rectal cancerPrajnan Das
Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
Am J Clin Oncol 29:219-24. 2006..To identify predictive factors for locoregional recurrence (LR), distant metastasis (DM), and overall survival (OS) in patients treated with chemoradiation and surgery for rectal cancer...
Targeting cell signaling pathways for drug discovery: an old lock needs a new keyBharat B Aggarwal
Department of Experimental Therapeutics, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
J Cell Biochem 102:580-92. 2007..This review analyzes the shortcomings of rationally designed target-specific drugs against cancer cell signaling pathways and evaluates the available options for future drug development...
Intraoperative radiotherapy using a mobile electron LINAC: a retroperitoneal sarcoma caseA Sam Beddar
Department of Radiation Physics, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
J Appl Clin Med Phys 6:95-107. 2005..We also discuss the roles and coordination of multidisciplinary team members during IORT and the feasibility of using mobile LINACs for IORT...
Choroid plexus papillomas: a single institutional experienceSunil Krishnan
Division of Radiation Oncology, Mayo Clinic, Rochester, Minnesota 55905, USA
J Neurooncol 68:49-55. 2004..After initial STR, reoperations for recurrence are required only half the time. Therefore, there seems to be no role for radiation therapy after initial STR. For STRs at first relapse, local control outcome is poor...
Gastrointestinal complications associated with hepatic arterial Yttrium-90 microsphere therapyRavi Murthy
Division of Diagnostic Imaging, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA
J Vasc Interv Radiol 18:553-61; quiz 562. 2007..Our aim is to increase the understanding of the role of various imaging and preventative techniques in minimizing this undesired effect...
Curcumin potentiates antitumor activity of gemcitabine in an orthotopic model of pancreatic cancer through suppression of proliferation, angiogenesis, and inhibition of nuclear factor-kappaB-regulated gene productsAjaikumar B Kunnumakkara
Department of Experimental Therapeutics, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA
Cancer Res 67:3853-61. 2007..018 versus control). Overall, our results suggest that curcumin potentiates the antitumor effects of gemcitabine in pancreatic cancer by suppressing proliferation, angiogenesis, NF-kappaB, and NF-kappaB-regulated gene products...
Combination of epidermal growth factor receptor targeted therapy with radiation therapy for malignant gliomasSunil Krishnan
Division of Radiation Oncology, Mayo Clinic and Foundation. 200 First Street, SW, Rochester, MN 55905, USA
Front Biosci 8:e1-13. 2003....
Back to basics: how natural products can provide the basis for new therapeuticsAmit Deorukhkar
The University of Texas MD Anderson Cancer Center, Department of Experimental Radiation Oncology, 1515 Holcombe Boulevard, Houston, Texas 77030, USA
Expert Opin Investig Drugs 16:1753-73. 2007..This review focuses on the mechanism of action of key natural products and promising preclinical data on their efficacy as anticancer agents, as single agents and in combination with standard therapies...
Radiosurgery for cranial base chordomas and chondrosarcomasSunil Krishnan
Division of Radiation Oncology, Department of Oncology, Mayo Clinic College of Medicine, Rochester, Minnesota, USA
Neurosurgery 56:777-84; discussion 777-84. 2005..Radiosurgery as an adjunct to surgical resection provides in-field tumor control for some patients, but radiation-related complications are relatively high, especially when radiosurgery is combined with fractionated radiation therapy...
Genetic and signaling pathway alterations in glioblastoma: relevance to novel targeted therapiesRavi D Rao
Section of Medical Oncology, Department of Oncology, Mayo Clinic and Foundation. 200 First Street, SW; Rochester, MN 55905, USA
Front Biosci 8:e270-80. 2003..In this review, we will describe the most common genetic and signaling pathway alterations that have relevance to new drug development for the treatment of GBM...
Imaging epidermal growth factor receptor expression in vivo: pharmacokinetic and biodistribution characterization of a bioconjugated quantum dot nanoprobeParmeswaran Diagaradjane
Department of Experimental Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
Clin Cancer Res 14:731-41. 2008..To develop and validate an optical imaging nanoprobe for the discrimination of epidermal growth factor (EGF) receptor (EGFR)-overexpressing tumors from surrounding normal tissues that also expresses EGFR...
